August 3, 2016
Ono Pharmaceutical’s immuno-oncology drug Opdivo (nivolumab) saw its sales rocket to 25.2 billion yen in April-June from 1.4 billion yen a year before, pushing up the company’s earnings for the first quarter of FY2016. The Japanese drug maker reported on...read more